US Patent Litigations are now available. Check here

IP Verse

Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient

PatentPatent Analysis

EP2395968

BOEHRINGER INGELHEIM
Application Number
EP10703652A
Filing Date
Feb 11, 2010
Status
Granted And Under Opposition
Dec 15, 2023
Grant Date
Jan 17, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2488145B1
EP3150200B1
EP2313087B2

Biblio Summary

The patent EP2395968B1 was granted on Jan 17, 2024 by Boehringer Ingelheim The patent is currently Granted And Under Opposition.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2008116179
 N/A
OppositionWO2008055940
 N/A
OppositionWO2006117359
 N/A
OppositionWO2009022007
 N/A
OppositionUS2005209166
 N/A
OppositionWO2005092877
 N/A
OppositionWO2007128749
 N/A
OppositionWO2010092124
 N/A
OppositionWO2010092126
 N/A
OppositionUS2008234367
 N/A
OppositionWO2008090210
 N/A
OppositionWO2008116195
 N/A
OppositionUS2007249544
 N/A
OppositionEP2187879
 N/A
OppositionWO0151463
 N/A
OppositionCA2557801
 N/A
OppositionUS2009023913
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents